Understanding Semaglutide Dosing: What is the Max Dose in Units for Effective Weight Loss?

Last reviewed: June 9, 2026

Last updated: June 9, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide works by slowing stomach emptying and signaling fullness to your brain—effects that require sufficient drug concentration in your system. Clinical trials show that most people respond to doses between 1.7 and 2.4 milligrams weekly, though your healthcare provider may adjust based on your tolerance and results.

How Semaglutide Dosing Works in Practice

Semaglutide treatment follows a step-up schedule rather than starting at a final dose. Most protocols begin at 0.25 mg weekly, then increase by 0.25 mg increments every 4 weeks until reaching a maintenance dose. This gradual approach lets your body adapt and reduces nausea and gastrointestinal side effects that occur with rapid escalation.

The typical maintenance range is 1.7 to 2.4 mg weekly for weight loss, based on JEDI and SELECT trial data showing maximal glycemic and weight-loss benefits in this window. Some people stabilize at lower doses if they experience good appetite suppression, while others tolerate and benefit from higher amounts. Your prescriber determines the right pace and target dose for your individual metabolism and tolerance.

Why Maximum Dose Isn't One-Size-Fits-All

Your genetic makeup influences how effectively you respond to GLP-1 receptor agonists. Variants in the GLP1R gene and related metabolic pathways affect peptide sensitivity, meaning two people at the same body weight may need different semaglutide doses to achieve similar appetite suppression. PlexusDx Precision Peptide Genetic Test maps 14 metabolic pathways and identifies your genetic insights into GLP-1 responsiveness so your dose can be tailored from the start.

Environmental factors like food choices, meal timing, and activity level also shape how high you need to go. Some patients reach their weight-loss goals at 1.0 mg weekly, while others benefit from titrating to 2.4 mg. Your provider adjusts based on hunger scores, weight loss, and side effect tolerance—not a preset ceiling.

Safety and Tolerability Considerations

Semaglutide is generally well-tolerated when doses are increased slowly, but gastrointestinal side effects—nausea, vomiting, constipation—are common during titration. These usually peak in the first 2–3 weeks after a dose increase and fade as your body adjusts. Staying hydrated, eating smaller meals, and choosing bland foods can ease the transition.

Rare but serious concerns include pancreatitis, gallbladder issues, and severe dehydration in people who vomit persistently. Report severe abdominal pain, persistent vomiting, or signs of dehydration to your healthcare provider immediately. For this reason, semaglutide may not be suitable if you have a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia type 2.

PlexusDx Semaglutide Pricing and Access

PlexusDx offers compounded semaglutide injection from licensed 503A pharmacies at $189/mo month-to-month, or from $149/mo on the 6-month plan, with no insurance required, no membership fees, and HSA/FSA eligibility. Your dose may need to go up as you progress through titration, but your price remains flat—you pay the same monthly cost whether you're at 0.25 mg or 2.4 mg. This pricing transparency means no surprise costs as your treatment advances.

The PlexusDx Precision Peptide Genetic Test ($298) reports on variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

What is the maximum semaglutide dose in units, and how high can I go?

The standard maximum dose is 2.4 mg (2,400 units) weekly for weight loss, as used in major clinical trials. Some patients stabilize at lower doses; others tolerate and benefit from the full 2.4 mg. Your prescriber sets your target based on your response, tolerability, and health history.

How long does it take to reach the full dose?

Typical titration takes 4 to 6 months, starting at 0.25 mg and increasing by 0.25 mg every 4 weeks. You may reach a therapeutic dose sooner if you respond well at lower increments, or your provider may slow the schedule if you experience side effects.

Does PlexusDx charge more if my dose goes higher?

No. PlexusDx semaglutide injection costs a flat $189/mo (or $149/mo on the 6-month plan) regardless of whether you're at 0.25 mg or 2.4 mg—your dose may go up, but your price won't. This applies across all commitment tiers.

What happens if I can't tolerate the full 2.4 mg dose?

Many people achieve excellent weight loss at lower maintenance doses like 1.0 to 1.7 mg and experience fewer side effects. Your provider can pause or slow titration and reassess after several weeks. Lower doses remain effective if combined with consistent nutrition and activity habits.

How does the Precision Peptide Genetic Test help with semaglutide dosing?

No — the Precision Peptide Genetic Test does not predict your response to semaglutide or any specific medication. It analyzes pathway-level variants that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Semaglutide For Weight Loss 2
• Semaglutide Tablets For Weight Loss
• Semaglutide Pills For Weight Loss
• Oral Semaglutide Weight Loss

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.